AwardedDNKGoods
Rammeaftale om køb af Kymriah® (tisagenlecleucel)
- Published
- Published 6 September 2024
Overview
Formålet med rammeaftalen er at kunne forsyne sygehusapotekerne hos Amgros' interessenter med lægemidlet Kymriah® (tisagenlecleucel). Region Hovedstadens sygehusapotek foretager endvidere indkøb med henblik på videresalg Grønland og Færøerne.
Key details
- Country
- DNK
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 6 September 2024
Pharmaceutical products
Award outcome
- Awarded value
- DKK 1
- Award date
- 1 April 2025
- Contract period
- 1 April 2025 → 30 September 2027
- AbbVie A/S
- Novartis Healthcare A/S
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
17 March 2026
Contract Notice
6 September 2024
Contract Notice
17 July 2024
Contracting authority
Amgros I/S
Procuring entityKøbenhavn Ø, DNK
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.